Cohance Lifesciences Limited (BOM:543064)
India · Delayed Price · Currency is INR 462.60
-12.95 (-2.72%)
At close: Aug 21, 2026
Cohance Lifesciences Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Cohance Lifesciences stock has a consensus rating of "Hold" and an average price target of ₹508.33. The average 1-year stock price forecast is 9.89% higher than the current stock price, while the lowest is ₹315.00 (-31.91%) and the highest is ₹1,150 (+148.59%).
Price Target: ₹508.33 (+9.89%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Cohance Lifesciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 2 | 2 | 2 | 2 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Financial Forecast
Revenue This Year
24.81B
from 22.69B
Increased by 9.35%
Revenue Next Year
29.83B
from 24.81B
Increased by 20.27%
EPS This Year
5.34
from 5.24
Increased by 1.95%
EPS Next Year
9.84
from 5.34
Increased by 84.22%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.